LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP) Files An 8-K Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities
On January 10, 2017 Lexaria Bioscience Corp. (the Company or
Lexaria) announced that it has received US$33,029.25from the
exercise of stock options and warrants previously granted. The
stock options were exercised at prices from US$0.10 to US$0.2273
for a total of 151,500 common shares being issued. The warrants
were exercised at prices of US$0.15 and US$0.14 for a total of
12,375 common shares being issued. All options and warrants are
being exercised by third parties who are neither officers nor
directors of the Company.
The Company has also issued 500,000 warrants to Correlation
Capital Inc, each warrant valid to purchase one restricted common
share at a price of US$0.44 for a period of one year.
No commissions or placement fees have been paid related to the
funds received from this warrant exercise. Proceeds raised are
for general corporate purposes.
– 2 –
The securities referred to herein will not be or have not
been registered under the United States Securities Act of 1933,
as amended, and may not be offered or sold in the United States
absent registration or an applicable exemption from registration
Item 7.01 Regulation FD Disclosure
A copy of the news release announcing that Lexaria has received
US$33,029.25from the exercise of stock options and warrants
previously granted is filed as exhibit 99.1 to this current
report and is hereby incorporated by reference.
Item 9.01 Financial Statements and Exhibits
|99.1||Press Release dated January 10, 2017|
About LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP)
Lexaria Bioscience Corp., formerly Lexaria Corp., is a food sciences company. The Company is focused on the delivery of cannabinoid compounds procured from legal, agricultural hemp, through gourmet foods based upon its infusion technologies. Its food sciences activities include the development of its nutrient infusion technologies for the production of superfoods, and the production of food products under its two consumer product brands, ViPova and Lexaria Energy. Its technology is developed to aid absorption and bioavailability of various payload molecules, including cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC). Its range of flavors to the ViPova family, are available in 8 to 32 bag portions: Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light. It produces and sells edible consumer products infused with cannabidiol and available for sale in over 50 states. LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP) Recent Trading Information
LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP) closed its last trading session up +0.035 at 0.595 with 2,459,322 shares trading hands.
ME Staff 8-k
Latest posts by ME Staff 8-k (see all)
- ONEOK PARTNERS, L.P. (NYSE:OKS) Files An 8-K Regulation FD Disclosure - January 11, 2017
- PANGAEA LOGISTICS SOLUTIONS LTD. (NASDAQ:PANL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - January 11, 2017
- LogMeIn, Inc. (NASDAQ:LOGM) Files An 8-K Regulation FD Disclosure - January 11, 2017